Dr. Maayan Levy received her Ph.D. in Immunology from the Weizmann Institute of Science. After completion of her PhD, Dr. Levy became an Assistant Professor at the Microbiology Department of the Perelman School of Medicine at the University of Pennsylvania. Dr. Levy has recently joined the Stanford Medicine Department of Pathology as an Assistant Professor and the Arc Institute as an Innovation Investigator in Residence.

Dr. Maayan Levy’s scientific mission is to understand, develop, and apply the concept of metabotherapy—the use of metabolites as vehicles and targets to prevent and treat disease. Her lab’s primary focus is on inflammatory diseases, neurological diseases, and cancer. Dr. Levy is particularly interested in the metabolite landscape of the gastrointestinal tract, which serves as a major metabolite source for many other tissues and as an ideal entry point for the introduction of new metabolites into the organism. She is exploring the repertoire of these intestinal metabolites, their impact on whole-body physiology, and the possibility of targeting them for therapeutic interventions.

Among the recognitions that Dr. Levy’s work has received are the NIH Director’s New Innovator Award, Pew Biomedical Scholar Award, Searle Scholar Award, and Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award.

The Levy lab is interested to understand, develop, and apply the concept of metabotherapy – the usage of metabolites as vehicles and targets to prevent and treat disease. We are exploring the landscape of these metabolites in different tissues, their impact on whole-body physiology, and the possibility to target them for therapeutic interventions for different diseases, including cancer, chronic inflammatory conditions, infections, and metabolic diseases.